| The autophagy‐enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease A Vasconcelos‐Ferreira, S Carmo‐Silva, JM Codêsso, P Silva, ... Neuropathology and Applied Neurobiology 48 (1), e12763, 2022 | 17 | 2022 |
| Characterization of lifestyle in spinocerebellar ataxia type 3 and association with disease severity H Hengel, P Martus, J Faber, H Garcia‐Moreno, N Solanky, P Giunti, ... Movement Disorders 37 (2), 405-410, 2022 | 9 | 2022 |
| The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors H Hengel, P Martus, J Faber, P Giunit, H Garcia-Moreno, N Solanky, ... Journal of Neurology 270 (2), 944-952, 2023 | 7 | 2023 |
| Stage‐dependent biomarker changes in spinocerebellar ataxia type 3 J Faber, M Berger, C Wilke, J Hubener‐Schmid, T Schaprian, ... Annals of neurology 95 (2), 400-406, 2024 | 4 | 2024 |
| A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia MM Santana, LS Gaspar, MM Pinto, P Silva, D Adao, D Pereira, ... Neuropathology and Applied Neurobiology 49 (2), e12892, 2023 | 1 | 2023 |
| E-learning in vocational education and training (VET): challenges and opportunities P Silva, J Luzia, J Ribeiro EDULEARN17 Proceedings, 6115-6119, 2017 | 1 | 2017 |
| Small non-coding RNA content in plasma-derived extracellular vesicles distinguish ataxic SCA3 mutation carriers from pre-ataxic and control subjects MM Santana, P Silva, MM Pinto, L Gaspar, R Nobre, S Duarte, ... | | 2024 |
| Correction to: The frequency of non‑motor symptoms in SCA3 and their association with disease severity and lifestyle factors H Hengel, P Martus, J Faber, P Giunti, H Garcia-Moreno, N Solanky, ... Journal of Neurology 271 (1), 628, 2024 | | 2024 |
| Small non-coding RNA content in plasma-derived extracellular vesicles distinguish ataxic SCA3 mutation carriers from pre-ataxic and control subjects M Matos Santana, P Silva, MM Pinto, L Gaspar, RJ Nobre, S Duarte, ... bioRxiv, 2024.01. 04.574044, 2024 | | 2024 |
| Characterization of Lifestyle inSpinocerebellar Ataxia Type 3 andAssociation with Disease Severity H Hengel, P Martus, J Faber, H Garcia-Moreno, N Solanky, P Giunti, ... John Wiley and Sons Inc., 2022 | | 2022 |
| Predictors of quality of life in Machado-Joseph disease: A longitudinal observational study I Cunha, P Silva, JA Ribeiro, M Santana, LP Almeida, C Januario MOVEMENT DISORDERS 35, S558-S558, 2020 | | 2020 |
| miRNA expression profile of plasma-derived extracellular vesicles distinguishes Machado-Joseph Disease patients from controls MM Santana, P Silva, L Gaspar, C Henriques, J Ribeiro, I Cunha, ... MEDICINE 99 (9), 2020 | | 2020 |
| Characterization of a Portuguese cohort of Machado-Joseph disease: besides ataxia A Bras, I Cunha, P Silva, JA Ribeiro, M Santana, LP Almeida, C Januario EUROPEAN JOURNAL OF NEUROLOGY 26, 170-170, 2019 | | 2019 |
| Characterization and follow-up of the Coimbra cohort of Machado-Joseph disease patients MM Santana, P Silva, J Ribeiro, I Cunha, L Gaspar, C Januario, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 49, 94-95, 2019 | | 2019 |
| Machado-Joseph Disease: Understanding Epidemiologic and Clinical Features and a Potential New Therapeutic Entity PJ Silva Machado-Joseph Disease: Understanding Epidemiologic and Clinical Features …, 2017 | | 2017 |
Magda SantanaUniversity of Coimbra, CNC - Center for Neuroscience and Cell Biology and Faculty of PharmacyEmail confirmado em uc.pt
